NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $756,412 | +11.0% | 7,426 | +9.9% | 0.10% | +12.6% |
| Q2 2023 | $681,546 | +41.6% | 6,754 | +29.1% | 0.09% | +31.8% |
| Q1 2023 | $481,160 | +99.2% | 5,230 | +96.5% | 0.07% | +69.2% |
| Q4 2022 | $241,497 | +13.4% | 2,662 | -4.9% | 0.04% | 0.0% |
| Q3 2022 | $213,000 | -29.7% | 2,800 | -21.9% | 0.04% | -29.1% |
| Q2 2022 | $303,000 | +7.8% | 3,587 | +12.0% | 0.06% | +12.2% |
| Q1 2022 | $281,000 | +26.6% | 3,203 | +26.0% | 0.05% | +16.7% |
| Q4 2021 | $222,000 | -7.1% | 2,542 | -12.9% | 0.04% | -23.6% |
| Q3 2021 | $239,000 | -12.1% | 2,919 | -2.0% | 0.06% | -16.7% |
| Q2 2021 | $272,000 | +16.7% | 2,978 | +9.1% | 0.07% | -2.9% |
| Q1 2021 | $233,000 | +2.2% | 2,730 | +13.0% | 0.07% | -12.8% |
| Q4 2020 | $228,000 | +4.6% | 2,416 | -3.4% | 0.08% | -12.4% |
| Q3 2020 | $218,000 | 0.0% | 2,502 | +0.2% | 0.09% | -10.1% |
| Q2 2020 | $218,000 | – | 2,496 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 335,936 | $29,213,000 | 5.81% |
| Martin Investment Management, LLC | 170,759 | $14,849,000 | 5.36% |
| Mawer Investment Management Ltd. | 8,515,391 | $740,498,000 | 4.84% |
| SCHARF INVESTMENTS, LLC | 1,212,354 | $105,426,000 | 4.54% |
| Hansberger Growth Investors, LP | 45,645 | $3,969,000 | 4.50% |
| GARLAND CAPITAL MANAGEMENT INC | 50,905 | $4,427,000 | 3.95% |
| First Fiduciary Investment Counsel, Inc. | 193,021 | $16,785,000 | 3.49% |
| PROFESSIONAL ADVISORY SERVICES INC | 224,087 | $19,487,000 | 3.48% |
| WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC | 362,047 | $31,484,000 | 3.29% |
| WILKINS INVESTMENT COUNSEL INC | 126,470 | $10,998,000 | 3.28% |